Published in Transfusion on May 25, 2012
Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother (2014) 0.90
Evaluation of Simultaneous Transmission of Chikungunya Virus and Dengue Virus Type 2 in Infected Aedes aegypti and Aedes albopictus (Diptera: Culicidae). J Med Entomol (2015) 0.84
Climate change projections of West Nile virus infections in Europe: implications for blood safety practices. Environ Health (2016) 0.82
Current epidemiology and clinical practice in arboviral infections - implications on blood supply in South-East Asia. ISBT Sci Ser (2014) 0.76
Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light. Am J Trop Med Hyg (2013) 0.75
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination. J Vis Exp (2015) 0.75
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use. Blood Transfus (2016) 0.75
Inactivation of model viruses and bacteria in human fresh frozen plasma using riboflavin and long wave ultraviolet rays. Iran J Microbiol (2017) 0.75
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49
Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J (2008) 3.39
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
Sequencing of Culex quinquefasciatus establishes a platform for mosquito comparative genomics. Science (2010) 3.18
A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med (2003) 2.89
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology (2003) 2.59
Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol (2005) 2.52
Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies. Vector Borne Zoonotic Dis (2006) 2.37
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg (2004) 2.02
Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol (2007) 1.94
The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg (2008) 1.88
An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites. Proc Natl Acad Sci U S A (2005) 1.87
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti. PLoS Negl Trop Dis (2012) 1.72
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion (2004) 1.66
Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol (2006) 1.62
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus. Am J Trop Med Hyg (2004) 1.60
Identification of microRNAs expressed in two mosquito vectors, Aedes albopictus and Culex quinquefasciatus. BMC Genomics (2010) 1.59
LARVAL COMPETITION DIFFERENTIALLY AFFECTS ARBOVIRUS INFECTION IN AEDES MOSQUITOES. Ecology (2005) 1.58
Pathogenomics of Culex quinquefasciatus and meta-analysis of infection responses to diverse pathogens. Science (2010) 1.58
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J Virol (2004) 1.57
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion (2013) 1.54
West Nile virus dissemination and tissue tropisms in orally infected Culex pipiens quinquefasciatus. Vector Borne Zoonotic Dis (2004) 1.51
The 2005-2006 Chikungunya epidemic in the Indian Ocean. Vector Borne Zoonotic Dis (2006) 1.50
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine (2009) 1.48
Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications. Anesth Analg (2012) 1.45
Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem Mol Biol (2005) 1.45
Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. Viral Immunol (2004) 1.44
Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg (2011) 1.42
Ultrastructural study of West Nile virus pathogenesis in Culex pipiens quinquefasciatus (Diptera: Culicidae). J Med Entomol (2005) 1.39
RNA interference-mediated knockdown of a GATA factor reveals a link to anautogeny in the mosquito Aedes aegypti. Proc Natl Acad Sci U S A (2003) 1.36
Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg (2005) 1.30
Year-round West Nile virus activity, Gulf Coast region, Texas and Louisiana. Emerg Infect Dis (2004) 1.28
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes. J Infect Dis (2008) 1.23
Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates. J Infect Dis (2008) 1.23
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis (2010) 1.23
Alterations in the Aedes aegypti transcriptome during infection with West Nile, dengue and yellow fever viruses. PLoS Pathog (2011) 1.22
Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One (2007) 1.21
Anopheles gambiae heat shock protein cognate 70B impedes o'nyong-nyong virus replication. BMC Genomics (2007) 1.20
Salivary gland morphology and virus transmission during long-term cytopathologic West Nile virus infection in Culex mosquitoes. Am J Trop Med Hyg (2007) 1.19
Evaluation of the function of a type I peritrophic matrix as a physical barrier for midgut epithelium invasion by mosquito-borne pathogens in Aedes aegypti. Vector Borne Zoonotic Dis (2008) 1.17
Potential arbovirus emergence and implications for the United Kingdom. Emerg Infect Dis (2006) 1.17
Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One (2010) 1.16
Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J Gen Virol (2006) 1.16
Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One (2010) 1.09
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol (2003) 1.04
Transcriptome changes in Culex quinquefasciatus (Diptera: Culicidae) salivary glands during West Nile virus infection. J Med Entomol (2010) 1.04
Oral transmission of West Nile virus in a hamster model. Am J Trop Med Hyg (2005) 1.03
Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS One (2010) 1.02
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion (2005) 1.01
Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev (2008) 1.01
Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol (2004) 1.00
Viruses of the family Bunyaviridae: are all available isolates reassortants? Virology (2013) 0.99
Relative susceptibilties of South Texas mosquitoes to infection with West Nile virus. Am J Trop Med Hyg (2007) 0.99
Genetic variation of St. Louis encephalitis virus. J Gen Virol (2008) 0.98
Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes. J Gen Virol (2005) 0.97
Nonviremic transmission of West Nile virus: evaluation of the effects of space, time, and mosquito species. Am J Trop Med Hyg (2007) 0.97
Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome. Virol J (2009) 0.96
Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion (2010) 0.93
Determinants of vector specificity of o'nyong nyong and chikungunya viruses in Anopheles and Aedes mosquitoes. Am J Trop Med Hyg (2006) 0.92
Zika Virus: Emergence and Emergency. Vector Borne Zoonotic Dis (2016) 0.92
Short report: comparison of oral infectious dose of West Nile virus isolates representing three distinct genotypes in Culex quinquefasciatus. Am J Trop Med Hyg (2008) 0.92
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation (2007) 0.92
Mutational analysis of the West Nile virus NS4B protein. Virology (2012) 0.92
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion (2009) 0.90
Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions. Transfusion (2010) 0.89
Vector competence of Australian mosquitoes for yellow fever virus. Am J Trop Med Hyg (2011) 0.89
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion (2005) 0.89
White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion (2010) 0.88
Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion (2012) 0.88
Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3'non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut. Am J Trop Med Hyg (2006) 0.88
The role of phenylalanine hydroxylase in melanotic encapsulation of filarial worms in two species of mosquitoes. Insect Biochem Mol Biol (2004) 0.88
In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion (2011) 0.88
Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J (2011) 0.87
Comparative sensitivity of the VecTest antigen-capture assay, reverse transcriptase-PCR, and cell culture for detection of West Nile virus in dead birds. Vector Borne Zoonotic Dis (2004) 0.86
Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology. Photochem Photobiol (2004) 0.86
Yellow fever virus infectivity for Bolivian Aedes aegypti mosquitoes. Emerg Infect Dis (2004) 0.84
Effective suppression of dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain. Virol J (2014) 0.83
Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis. J Neuroimmunol (2006) 0.83
Characterization of the antigen distribution and tissue tropisms of three phenotypically distinct yellow fever virus variants in orally infected Aedes aegypti mosquitoes. Vector Borne Zoonotic Dis (2008) 0.83
Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion (2013) 0.83
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion (2009) 0.82
Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion (2013) 0.82
In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis (2011) 0.82
Chemical and biological mechanisms of pathogen reduction technologies. Photochem Photobiol (2014) 0.82
Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion (2011) 0.82